Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

26-04-2024(Fri) 25-04-2024(Thu) 24-04-2024(Wed) 23-04-2024(Tue) 22-04-2024(Mon)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
6 Jul, 2020 (Monday)

            
L'OCCITANE(973)
Analysis¡G
For the year ended 31 March 2020, L'Occitane (973) reported net sales of £á1,644.1 million, representing growth of 15.2% at reported rates. Net profit was £á115.2 million, a decrease of 2%. However, operating margin improved by 0.8 points to 11.4% as the Group's 'Pulse' strategy to build trust, pursue sustainable growth and drive profitability continued to bear fruit. The five pillars under its 'Pulse' strategy are: empowering teams; executing fundamentals especially in a retail context; adopting an omni-channel, mobile and digital approach; engaging customers; and strengthening brand commitments. Recommended (I do not hold the above stock).
Strategy¡G
Buy-in Price: $13.60, Target Price: $15.50, Cut Loss Price: $12.80


JACOBSON PHARMA(2633)
Analysis¡G
Jacobson Pharma Corporation (2633.HK) is a pharmaceutical company in Hong Kong. The group is principally engaged in the manufacture and trading of generic and brand-name drugs. Has a vertically integrated business, from product development, production, distribution, sales to logistics are provided by the company. Among them, brand-name drugs include PoChai Pill and Tong Tai Chung Woodlok Oil, which are well-known Chinese patent medicines in Hong Kong. Affected by COVID-19, the number of patients visiting clinics decreased in Q4, which affected the growth in the Group`s generic drug business. Sales revenue in FY2020 recorded a positive growth of 3.6% to HK$1,298.7 million. The Group will strive to expand E-commerce in the coming year and was invited by Tmall to open megastore on its platform. Currently, only six groups have been invited.
Strategy¡G
Buy-in Price: $1.20, Target Price: $1.40, Cut Loss Price: $1.10



Report Review of June. 2020

Sectors:

Air & Automobiles (Zhang Jing),

Automobile & Air (ZhangJing)

This month I released 4 updated reports of Zhongsheng (881.HK), Minth(425.HK), FLAT Glass (6865.HK) and Inovance (300124.CH), which got success by their unique Competitive edge. Among them, we highly recommend FLAT Glass (6865.HK).

In 2019, the sales volume of PV glass of the Company reached 160 million square meters, up by 67% yoy. The gross margin of the Company increased by 5.18 ppts to 32.87% because of the recovering price of PV glass, improvement of production efficiency of the newly-commissioned production capacity and improvement of product mix (thin glass accounted for a higher proportion). The proportion of revenue from PV glass increased to 78%, approaching 80%. Total production capacity increased to 5400 tons/day.

Flat Glass recorded a revenue of RMB4,807 million in 2019, up by 56.9% yoy because of the rise of unit price resulting from commission of new production capacity and the recovery of demand, net profit attributable to the parent company of RMB717 million, up by 76% yoy.

In Q1 2020, the Company recorded a revenue of RMB1,203 million, up by 29.10% yoy; net profit of RMB215 million, up by 97.0% yoy. Because of the continuance of effect of price yoy lift of PV glass, plus with the low material price, 2020Q1 gross margin continued to hike, reaching a historic height of 39.88%.

In 2019, domestic PV market tightened, but great performance was reported in overseas market, with export increasing rapidly. Strong overseas momentum was continued in Q1 2020, which compensated the shortage of domestic demand due to domestic suspense of work. In Q2, the delay of overseas demand caused by the pandemic put pressure on the price of PV glass, which may exert some negative impact on the results of the Company in 2020 Q2. However, the revenue from European and American markets only accounted for 10% of the total revenue of the Company. We expected that the demand side will improve steadily from H2 because of the reopen. Looking forward, the PV industry has entered the phase of scale competition. The concentration of the industry continuously roused, and the total market share of the Company and Xinyi Solar has exceeded 50%, which helped the double-oligarchy layout taking shape.

Recently, the Company announced that it would release convertible bonds of RMB1.45 billion and Private placement of RMB2 billion, which were mainly used in the production and construction of the two 1,200-ton-per-day production lines (Line 4/Line 5), as well the preparation and construction of Line 6/ Line 7 (also 1,200 tons per day) in Fengyang, Anhui. Due to obvious advantages in technology and scale of newly increased capacity, increase in finished production rate and decrease in unit cost will further improve the profitability of the Company.

Click Here for PDF format...




Writer Info
Research Department
Tel: +86 21 51699400-105
Email:
research@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2020 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]